Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
Icona ATCO ILM 2016 (ATCO LAB PAK)

1.7 by WAEMS ENTERPRISES


Oct 11, 2016

Informazioni su ATCO ILM 2016 (ATCO LAB PAK)

Pakistan's 1st Pharmaceutical Reference & Evidence Based Mobile Application

ATCO ILM Pakistan’s 1st Pharmaceutical Reference and Evidence based drug information application. Provide all available Pakistani Pharmaceutical Brands information and reference based drug monographs, along with Top leading Journals updates.

There is 9 options are available:

1- Monographs: provide complete Drug prescribing information with references.

2- Brand Search: provide more than 33,000 brands details. (Pharmaceuticals)

3- Journals: Provide Top 35 Leading Journals RSS Feeds.

4- News & Updates: This Option Provide Pakistani Healthcare Market Current News along with FDA & Medscape Latest Updated Through RSS Feed Option.

Searching Criteria is: Company Name, Brand Name, Generic and Group Name.

For Free Activation Key Please Contact ATCO LABORATORIES REPRESENTATIVE.

Contact: [email protected]

Novità nell'ultima versione 1.7

Last updated on Oct 11, 2016

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Traduzione in caricamento...

Informazioni APP aggiuntive

Ultima versione

Richiedi aggiornamento ATCO ILM 2016 (ATCO LAB PAK) 1.7

Caricata da

Đồng Đức Thịnh

È necessario Android

Android 3.0+

Mostra Altro

ATCO ILM 2016 (ATCO LAB PAK) Screenshot

Commento Loading...
Lingua
Iscriviti ad APKPure
Sii il primo ad accedere alla versione anticipata, alle notizie e alle guide dei migliori giochi e app Android.
No grazie
Iscrizione
Abbonato con successo!
Ora sei iscritto ad APKPure.
Iscriviti ad APKPure
Sii il primo ad accedere alla versione anticipata, alle notizie e alle guide dei migliori giochi e app Android.
No grazie
Iscrizione
Successo!
Ora sei iscritto alla nostra newsletter.